Analyze Diet

Topic:West Nile Virus

West Nile Virus (WNV) is a mosquito-borne virus that affects horses, causing neurological disease. It is transmitted primarily through the bite of infected mosquitoes, which acquire the virus from feeding on infected birds. Horses are considered a dead-end host, meaning they do not contribute to the transmission cycle of the virus. Clinical signs in horses can range from mild fever and lethargy to severe neurological symptoms such as ataxia, weakness, and paralysis. Diagnosis is typically confirmed through serological testing or detection of the virus in tissues. Vaccination is available and serves as a preventive measure to reduce the incidence of the disease. This page compiles peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, clinical presentation, and management of West Nile Virus in equine populations.
Serum antibodies to West Nile virus in naturally exposed and vaccinated horses.
Journal of medical microbiology    August 23, 2008   Volume 57, Issue Pt 9 1087-1093 doi: 10.1099/jmm.0.47849-0
Magnarelli LA, Bushmich SL, Anderson JF, Ledizet M, Koski RA.A polyvalent ELISA and plaque reduction neutralization tests (PRNTs) were used to measure serum antibodies to West Nile virus (WNV) in horses naturally exposed to or vaccinated against this flavivirus in Connecticut and New York State, USA. Relying on a PRNT as a 'gold standard', the main objective was to validate a modified ELISA containing a recombinant WNV envelope protein antigen. It was also important to assess specificity by testing sera from horses that had other, undiagnosed illnesses. Sera for the latter study were obtained from 43 privately owned horses during 1995-1996. Analyses by ...
North American encephalitic arboviruses.
Neurologic clinics    July 29, 2008   Volume 26, Issue 3 727-ix doi: 10.1016/j.ncl.2008.03.012
Davis LE, Beckham JD, Tyler KL.Arboviruses continue to be a major cause of encephalitis in North America, and West Nile virus neuroinvasive disease is now the dominant cause of encephalitis. Transmission to humans of North American arboviruses occurs by infected mosquitoes or ticks. Most infections are asymptomatic or produce a flulike illness. Rapid serum or cerebrospinal fluid IgM antibody capture ELISA assays are available to diagnosis the acute infection for all North American arboviruses. Unfortunately, no antiviral drugs are approved for the treatment of arbovirus infection and current therapy is supportive.
The economic impact of West Nile virus infection in horses in the North Dakota equine industry in 2002.
Tropical animal health and production    June 14, 2008   Volume 40, Issue 1 69-76 doi: 10.1007/s11250-007-9055-8
Ndiva Mongoh M, Hearne R, Dyer NW, Khaitsa ML.This study estimated economic impacts associated with the West Nile virus (WNV) outbreak in horses for North Dakota in 2002. The 2002 epidemic in the United States was the largest meningoencephalitis epidemic reported in the Western Hemisphere. Over 15,257 horse cases were reported in 43 states with most cases occurring in central United States. North Dakota reported over 569 horse cases, with a mortality rate of 22%. The total costs incurred by the state were approximately US$1.9 million. The costs incurred by horse owners were about US$1.5 million. Of the US$1.5 million, about US$781,203 and...
Surveillance for West Nile virus in horses.
The Veterinary record    June 10, 2008   Volume 162, Issue 23 763 doi: 10.1136/vr.162.23.763-a
Drummond R.This research article focuses on the monitoring of West Nile Virus (WNV) in horses, highlighting the importance of reporting any suspected WNV infection case to a local Animal Health office. […]
Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus.
Nature biotechnology    April 20, 2008   Volume 26, Issue 5 571-577 doi: 10.1038/nbt1400
Chang DC, Liu WJ, Anraku I, Clark DC, Pollitt CC, Suhrbier A, Hall RA, Khromykh AA.DNA vaccines encoding replication-defective viruses are safer than inactivated or live attenuated viruses but may fail to stimulate an immune response sufficient for effective vaccination. We augment the protective capacity of a capsid-deleted flavivirus DNA vaccine by co-expressing the capsid protein from a separate promoter. In transfected cells, the capsid-deleted RNA transcript is replicated and translated to produce secreted virus-like particles lacking the nucleocapsid. This RNA is also packaged with the help of co-expressed capsid protein to form secreted single-round infectious particl...
Pathological, entomological, avian and meteorological investigation of a West Nile virus epidemic in a horse farm.
Transboundary and emerging diseases    April 10, 2008   Volume 55, Issue 2 134-139 doi: 10.1111/j.1865-1682.2007.01006.x
Sebastian MM, Stewart I, Williams NM, Poonacha KB, Sells SF, Vickers ML, Harrison LR.Pathological, entomological and avian investigations were conducted during the summer of 2002, in a horse farm that had four cases of West Nile virus (WNV) infection in horses. All the four horses had encephalitis and WNV infection was confirmed by RT-PCR and in situ hybridization procedure. Forty-seven per cent of house sparrows that resided on the farm were tested positive for WNV infection. Mosquitoes (98%Culex pipiens) collected by trapping at the farm, during this period were positive for WNV. The meteorological data for year 2002 were compared to previous 16 years. The precipitation and ...
Limited interdecadal variation in mosquito (Diptera: Culicidae) and avian host competence for Western equine encephalomyelitis virus (Togaviridae: Alphavirus).
The American journal of tropical medicine and hygiene    April 4, 2008   Volume 78, Issue 4 681-686 
Reisen WK, Fang Y, Brault AC.Historically, western equine encephalomyelitis virus (WEEV) caused large equine and human epidemics in the Americas from Canada into Argentina. Despite recent enhanced surveillance for West Nile virus, there have been few reports of equine or human cases and little documented enzootic activity of WEEV. During the past three years, WEEV has been active again in California, but without human or equine cases. In the current study, we compared host and vector competence of representative WEEV isolates made during each decade over the past 60 years using white-crowned sparrows, house sparrows, and ...
Transmission dynamics and changing epidemiology of West Nile virus.
Animal health research reviews    March 19, 2008   Volume 9, Issue 1 71-86 doi: 10.1017/S1466252307001430
Blitvich BJ.West Nile virus (WNV) is a flavivirus that is maintained in a bird-mosquito transmission cycle. Humans, horses and other non-avian vertebrates are usually incidental hosts, but evidence is accumulating that this might not always be the case. Historically, WNV has been associated with asymptomatic infections and sporadic disease outbreaks in humans and horses in Africa, Europe, Asia and Australia. However, since 1994, the virus has caused frequent outbreaks of severe neuroinvasive disease in humans and horses in Europe and the Mediterranean Basin. In 1999, WNV underwent a dramatic expansion of ...
[Introduction of West Nile virus in the Netherlands].
Tijdschrift voor diergeneeskunde    March 4, 2008   Volume 133, Issue 3 106-107 
Klinkhamer K, Lipman LJ.No abstract available
Identification of hyperendemic foci of horses with West Nile virus disease in Texas.
American journal of veterinary research    March 4, 2008   Volume 69, Issue 3 378-384 doi: 10.2460/ajvr.69.3.378
Wittich CA, Ward MP, Fosgate GT, Srinivasan R.To determine whether West Nile virus (WNV) disease hyperendemic foci (hot spots) exist within the horse population in Texas and, if detected, to identify the locations. Methods: Reports of 1,907 horses with WNV disease in Texas from 2002 to 2004. Methods: Case data with spatial information from WNV epidemics occurring in 2002 (1,377 horses), 2003 (396 horses), and 2004 (134 horses) were analyzed by use of the spatial scan statistic (Poisson model) and kriging of empirical Bayes smoothed county attack rates to determine locations of horses with WNV disease in which affected horses were consiste...
Hematophagous Diptera collected from a horse and paired carbon dioxide-baited suction trap in southern California: relevance to West Nile virus epizootiology.
Journal of medical entomology    February 21, 2008   Volume 45, Issue 1 115-124 doi: 10.1603/0022-2585(2008)45[115:hdcfah]2.0.co;2
Gerry AC, Nawaey TM, Sanghrajka PB, Wisniewska J, Hullinger P.Hematophagous Diptera landing on a horse were removed by vacuum, and their numbers were related to a paired carbon dioxide-baited suction trap at three locations in southern California where West Nile virus activity was high during the preceding year. Insects collected from the horse included mosquitoes (nine species), biting midges (Culicoides sonorensis Wirth & Jones), and black flies (Simulium bivittatum Malloch). Mosquitoes were predominantly collected from the head, crest, withers, neck, chest, and shoulders of the horse, whereas biting midges and black flies were predominantly collected ...
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
Veterinary immunology and immunopathology    February 16, 2008   Volume 123, Issue 3-4 230-239 doi: 10.1016/j.vetimm.2008.02.002
El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V.Successful vaccination against West Nile virus (WNV) requires induction of both neutralizing antibodies and cell-mediated immune responses. In this study, we have assessed the ability of a recombinant ALVAC-WNV vaccine (RECOMBITEK WNV) to elicit neutralizing antibodies and virus-specific cell-mediated immune responses in horses. In addition, we examined whether prior exposure to ALVAC-WNV vaccine would inhibit B and cell-mediated immune responses against the transgene product upon subsequent booster immunizations with the same vaccine. The results demonstrated that the recombinant ALVAC-WNV va...
High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection.
The American journal of tropical medicine and hygiene    January 12, 2008   Volume 78, Issue 1 45-52 
Nielsen CF, Reisen WK, Armijos MV, Maclachlan NJ, Scott TW.Although horse cases frequently are reported during West Nile virus (WNV) outbreaks, few investigations have focused on the epidemiology of this transmission. From April to October 2003 to 2005, mosquito abundance and infection were monitored 3 days per week at an equine research facility at the University of California, Davis. Thirty-two nonvaccinated horses enrolled as controls in a vaccine study were bled monthly, and their serum was tested for evidence of WNV infection by plaque reduction neutralization test (PRNT). In 2004, one positive Culex pipiens pool was associated with a single hors...
The evolving means of protecting horses against West Nile infection through immunisation.
Equine veterinary journal    December 11, 2007   Volume 39, Issue 6 484-485 doi: 10.2746/042516407X247116
Traub-Dargatz JL, Cordes T, Evans MB.No abstract available
Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
Equine veterinary journal    December 11, 2007   Volume 39, Issue 6 486-490 doi: 10.2746/042516407X214473
Long MT, Gibbs EP, Mellencamp MW, Zhang S, Barnett DC, Seino KK, Beachboard SE, Humphrey PP.West Nile virus (WNV) infection is endemic and able to cause disease in naive hosts. It is necessary therefore to evaluate the safety of new vaccines. Objective: To establish: 1) the safety of a modified live Flavivirus/West Nile virus (WN-FV) chimera by administration of an overdose and testing for shed of vaccine virus and spread to uninoculated sentinel horses; 2) that this vaccine did not become pathogenic once passaged in horses; and 3) vaccine safety under field conditions. Methods: There were 3 protocols: 1) In the overdose/shed and spread study, horses were vaccinated with a 100x immun...
Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Equine veterinary journal    December 11, 2007   Volume 39, Issue 6 491-497 doi: 10.2746/042516407X217416
Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP.West Nile virus (WNF) is a Flavivirus responsible for a life-threatening neurological disease in man and horses. Development of improved vaccines against Flavivirus infections is therefore important. Objective: To establish that a single immunogenicity dose of live Flavivirus chimera (WN-FV) vaccine protects horses from the disease and it induces a protective immune response, and to determine the duration of the protective immunity. Methods: Clinical signs were compared between vaccinated (VACC) and control (CTRL) horses after an intrathecal WNV challenge given at 10 or 28 days, or 12 months p...
Factors associated with West Nile virus disease fatalities in horses.
The Canadian veterinary journal = La revue veterinaire canadienne    December 7, 2007   Volume 48, Issue 11 1137-1145 
Epp T, Waldner C, West K, Townsend H.In 2003, the occurrence and location of horses with clinical signs of West Nile virus infection were identified in the southern portion of Saskatchewan with the help of veterinarians, owners, and the regional laboratory. A total of 133 clinical cases were reported between July 30 and September 19, 2003; however, postseason surveillance suggests that the number of cases was underestimated. The case fatality rate was 43.8% (95% CI 35.2, 52.4). Factors associated with fatality in clinical cases included sex, week of onset of clinical signs, and coat color. Reported clinical cases clustered within...
Monoclonal antibodies to equine IgM improve the sensitivity of West Nile virus-specific IgM detection in horses.
Veterinary immunology and immunopathology    December 3, 2007   Volume 122, Issue 1-2 46-56 doi: 10.1016/j.vetimm.2007.10.013
Wagner B, Glaser A, Hillegas JM, Erb H, Gold C, Freer H.West Nile virus (WNV) is a zoonotic pathogen of global importance. In horses with neurological signs, detection of WNV-specific immunoglobulin M (IgM) in serum is widely used to identify clinical cases of WNV encephalitis. Here, we describe the development of two monoclonal antibodies (mAbs) to equine IgM which were used in a WNV IgM-specific enzyme-linked immunosorbent assay (ELISA). Their performance was compared to an established assay based on polyclonal anti-IgM. Check test serum samples from the National Veterinary Service Laboratory (NVSL) were used to evaluate the performance of the th...
The relationship between equine and human West Nile virus disease occurrence.
Veterinary microbiology    November 29, 2007   Volume 129, Issue 3-4 378-383 doi: 10.1016/j.vetmic.2007.11.022
Ward MP, Scheurmann JA.Cases of human and equine West Nile virus (WNV) disease reported in Texas in 2002 were analyzed to assess their temporal relationship. For each human case with a known residential location, the closest equine case (within a 5 km radius) was selected. A total of 80 human-equine case pairs were identified, 51 (64%) of which were located in urban areas. Dates-of-onset of human and equine cases were positively correlated (r(SP)=0.494, P<0.001). Although overall there was no significant (P=0.207) difference between the dates-of-onset of human and equine cases, in urban areas of Texas equine case...
Seroprevalence and risk factors for infection with West Nile virus in Saskatchewan horses, 2003.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire    October 25, 2007   Volume 71, Issue 4 256-263 
Epp T, Waldner C, Leighton FA, Berke O, Townsend HG.The primary objectives of this study were to determine the seroprevalence of West Nile virus (WNV) infection of horses in Saskatchewan in 2003 and to identify risk factors for the infection. Blood samples were collected in August and October from 212 horses in 20 herds in 5 geographic zones. After accounting for within-herd clustering, the proportion of horses that had been infected with WNV, as determined by IgG and IgM antibody response, was 55.7% (95% confidence interval, 44.9% to 65.8%). The proportion of antibody-positive horses differed among herds (0% to 100%) and across ecoregions (20%...
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Vaccine    October 15, 2007   Volume 25, Issue 49 8338-8345 doi: 10.1016/j.vaccine.2007.09.055
Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J.Studies were performed with an inactivated vaccine against the mosquito-borne flavivirus, West Nile virus (WNV). The mammalian cell line, PER.C6, was selected as the platform for WNV growth since both the neurovirulent strains NY99 and ISR98 that cause epidemics in humans and high mortality in geese, respectively, could be propagated to high titers (10(9) to 10(10)TCID(50)/ml) on these cells. Based on the high DNA homology of the WNV envelope (E) protein and non-structural protein 5 (NS5), and identical neurovirulence in mice and geese, we concluded that NY99 and ISR98 viruses are closely rela...
Using geographic information systems and spatial and space-time scan statistics for a population-based risk analysis of the 2002 equine West Nile epidemic in six contiguous regions of Texas.
International journal of health geographics    September 21, 2007   Volume 6 42 doi: 10.1186/1476-072X-6-42
Lian M, Warner RD, Alexander JL, Dixon KR.In 2002, West Nile virus (WNV) first appeared in Texas. Surveillance data were retrospectively examined to explore the temporal and spatial characteristics of the Texas equine WNV epidemic in 2002. Using Geographic Information Systems (GIS) and the Spatial and Space-Time Scan (SaTScan) statistics, we analyzed 1421 of the reported equine WNV cases from six contiguous state Health Service Regions (HSRs), comprising 158 counties, in western, northern, central and eastern Texas. Results: Two primary epidemic peaks occurred in Epidemiological (Epi) week 35 (August 25 to 31) and Epi week 42 (October...
West Nile virus outbreak detection using syndromic monitoring in horses.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    September 5, 2007   Volume 7, Issue 3 403-410 doi: 10.1089/vbz.2006.0593
Leblond A, Hendrikx P, Sabatier P.Recent outbreaks of West Nile virus-associated (WNV) diseases, both in the old World and Americas, underline the importance for early warning systems that rapidly identify emerging and re-emerging diseases and thus help in their control. Traditional approaches of disease monitoring become less reliable and increasingly costly when used for rare health-related events, such as WNV outbreaks in southern France. The objective of this work was to discuss methodological issues related to syndromic monitoring of WNV-associated disease in Camargue horses by veterinary practitioners. Tracking cases of ...
Serosurvey of West Nile virus in equids and bovids in Spain.
The Veterinary record    August 19, 2007   Volume 161, Issue 6 212 doi: 10.1136/vr.161.6.212
Jiménez-Clavero MA, Tejedor CG, Rojo G, Soriguer R, Figuerola J.No abstract available
Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
Clinical and vaccine immunology : CVI    August 8, 2007   Volume 14, Issue 11 1465-1471 doi: 10.1128/CVI.00249-07
Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, Humphrey PP, Dixon MA, Bourgeois MA.We used a severe challenge model that produces clinical West Nile virus (WNV) disease to test the efficacy of three commercially available equine WNV vaccines in horses. Twenty-four healthy, WNV-seronegative horses of varying ages and genders were placed, in random and blind manner, into three trial groups consisting of eight horses each; two horses in each group received (i) an inactivated WNV vaccine (K-WN), (ii) a modified-live vaccine (CP-WN) containing the WNV prM and E proteins expressed by a canarypox vector, (iii) a live-chimera vaccine (WN-FV) containing WNV prM and E proteins express...
Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
Clinical and vaccine immunology : CVI    June 27, 2007   Volume 14, Issue 8 1024-1031 doi: 10.1128/CVI.00051-07
Kitai Y, Shoda M, Kondo T, Konishi E.West Nile virus (WNV) is now widely distributed worldwide, except in most areas of Asia where Japanese encephalitis virus (JEV) is distributed. Considering the movement and migration of reservoir birds, there is concern that WNV may be introduced in Asian countries. Although manuals and guidelines for serological tests have been created in Japan in preparedness for the introduction of WNV, differential diagnosis between WNV and JEV may be complicated by antigenic cross-reactivities between these flaviviruses. Here, we generated a monoclonal antibody specific for the nonstructural protein 1 (NS...
[Presence of west Nile virus in northeast Mexico].
Salud publica de Mexico    June 26, 2007   Volume 49, Issue 3 210-217 doi: 10.1590/s0036-36342007000300006
Fernández-Salas I, de Lourdes Garza-Rodríguez M, Beaty BJ, Jiménez JR, Rivas-Estilla AM.To investigate the presence of WNV in birds, horses and humans in northeast Mexico. Methods: Serum samples from 33 birds, 24 horses and 237 humans were screened by ELISA for Anti-WNV antibodies. Human serum samples were also screened for WNV RNA using an RT-PCR assay. Results: Positive sera were found in three birds and 15 horses. Forty percent of the human serum samples were positive for IgG antibodies and 0% for IgM antibodies and viral RNA. Conclusions: The results of this study show that WNV is present in northeast Mexico and it is a new emergent infectious agent that represents a challeng...
Serological evidence for West Nile virus infection in horses in Croatia.
The Veterinary record    June 5, 2007   Volume 160, Issue 22 772-773 doi: 10.1136/vr.160.22.772
Madić J, Savini G, Di Gennaro A, Monaco F, Jukić B, Kovac S, Rudan N, Listes E.No abstract available
Experimental infections with West Nile virus.
Current opinion in infectious diseases    May 2, 2007   Volume 20, Issue 3 293-297 doi: 10.1097/QCO.0b013e32816b5cad
Bowen RA, Nemeth NM.West Nile virus emerged recently in North America as a serious human and animal pathogen. This review summarizes the use of experimental infections with West Nile virus in diverse vertebrate species that have been used to answer fundamental questions about the host response, pathogenesis of West Nile virus infection and virus evolution. Results: West Nile virus has an extremely broad vertebrate host range. Infection of common species of birds has defined those with high vs. low potential to serve as amplifying hosts for the virus. In general, mammals (primates, horses, companion animals) are d...
West Nile Virus in horses, sub-Saharan Africa.
Emerging infectious diseases    March 1, 2007   Volume 12, Issue 12 1958-1960 doi: 10.3201/eid1212.060042
Cabre O, Grandadam M, Marié JL, Gravier P, Prangé A, Santinelli Y, Rous V, Bourry O, Durand JP, Tolou H, Davoust B.To evaluate the presence and extension of West Nile virus where French soldiers are stationed in Africa, specific antibody prevalence was determined by using ELISA and Western blot. Among 245 horses living in close proximity to the soldiers, seroprevalence was particularly high in Chad (97%) and Senegal (92%).
1 10 11 12 13 14 17